Literature DB >> 88900

Human fibroblasts produce "pregnancy-specific" beta-1 glycoprotein in vitro.

S W Rosen, J Kaminska, I S Calvert, S A Aaronson.   

Abstract

Normal and genetic variant strains of nonmalignant human fibroblasts produce in vitro a substance indistinguishable from the recently described "pregnancy-specific" beta-1 glycoprotein (PSbetaG, PAPP-C, SP1). Demonstration of this presumed placenta-specific material in a nonplacental site raises questions about its normal physiologic role and use as a cancer marker.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 88900     DOI: 10.1016/0002-9378(79)90938-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

1.  Serum concentration of placental proteins in non-pregnant and pregnant subjects.

Authors:  A G Ahmed; A Klopper
Journal:  Arch Gynecol       Date:  1985

2.  Pregnancy specific beta 1-glycoprotein and alpha 2-pregnancy associated globulin in tumours of the female genital tract.

Authors:  H Ludwig; G Tatra
Journal:  Klin Wochenschr       Date:  1981-07-15

3.  Ectopic synthesis of pregnancy specific beta 1-glycoprotein (SP1) and placental specific tissue proteins (PP5, PP10, PP11, PP12) in nontrophoblastic malignant tumours. Possible markers in oncology.

Authors:  N Inaba; T Renk; K Wurster; W Rapp; H Bohn
Journal:  Klin Wochenschr       Date:  1980-08-01

4.  Systematic Review of Postfertilization Effects and Potential for Embryo Formation and Loss during the Use of Intrauterine Devices.

Authors:  Cara Buskmiller; Donna Harrison; Lester A Ruppersberger; Patrick P Yeung
Journal:  Linacre Q       Date:  2019-06-27

5.  Oncofetal markers CA 19-9, CA 125 and SP1 in healthy children and in children with malignancy.

Authors:  M Heikinheimo; J Rajantie; P Kuusela; M J Kallio; M A Siimes
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

6.  Cells from normal brain and gliomas synthesize pregnancy-specific beta 1-glycoprotein-like material in vitro.

Authors:  M Heikinheimo; R Paasivuo; T Wahlström
Journal:  Br J Cancer       Date:  1981-05       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.